DH Stock Analysis: Buy, Sell, or Hold?
DH - Definitive Healthcare Corp. Class A Common Stock
$2.32
0.04 (1.75%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When DH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.08
Based on 4.3% avg growth
INTRINSIC VALUE TODAY
$1.91
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DH is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.35 to $2.64. The stock's valuation (Forward PE: 9.1) is in line with its historical norms (9.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $2.21, while resistance sits at $2.58.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.91 (+68.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DH is in a strong downtrend. Immediate support is located at $2.21, while resistance sits at $2.58.
Market Sentiment: DH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $3.91 (+68.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.35 -
$2.64
Company Quality Score
50/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding DH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 68.4% below Wall St target ($3.91)
Fair Price Analysis
30-Day Fair Range
$2.35 -
$2.64
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.29
(12.6%)
Support & Resistance Levels
Support Level
$2.21
Resistance Level
$2.58
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
9.08
Wall Street Target
$3.91
(+68.4%)
Revenue Growth (YoY)
-4.2%
Profit Margin
-77.9%
Valuation Discount vs History
-2.5% cheaper
PE vs Historical
9.1 vs 9.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.5%
(market-implied from PE analysis)
1-Year Target
$2.26
(-3%)
2-Year Target
$2.21
(-5%)
3-Year Target
$2.15
(-7%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$2.32
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 4.5%)
$6.51
(+181%)
Base:
(SPY PE: 9.1, Growth: 4.5%)
$2.65
(+14%)
Bear:
(PE: 7.7, Growth: 4.5%)
$2.25
(-3%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.1 to 9.8
Stabilization Target:
$2.50
(+7.9%)
PE Expansion Potential:
+7.9%
Last updated: February 01, 2026 1:08 PM ET
Data refreshes hourly during market hours. Next update: 2:08 PM
Data refreshes hourly during market hours. Next update: 2:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$310 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$29 | 48 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$119 | 55 HOLD |
Advanced DH Option Strategies
Professional options setups generated by AI based on today's DH price and gamma walls.
